Your Health Limited 03087838 false 2023-11-30 2024-11-29 2024-11-29 The principal activity of the company is running care homes Digita Accounts Production Advanced 6.30.9574.0 true true true true true true true true 03087838 2023-11-30 2024-11-29 03087838 2024-11-29 03087838 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-11-29 03087838 bus:PreferenceShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-11-29 03087838 core:CurrentFinancialInstruments 2024-11-29 03087838 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-29 03087838 core:CurrentFinancialInstruments core:WithinOneYear 2 2024-11-29 03087838 core:FurnitureFittingsToolsEquipment 2024-11-29 03087838 core:LandBuildings 2024-11-29 03087838 core:MotorVehicles 2024-11-29 03087838 core:OtherPropertyPlantEquipment 2024-11-29 03087838 core:DeferredTaxation 2024-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-11-29 03087838 core:OtherRelatedParties 2024-11-29 03087838 core:ParentEntities 2024-11-29 03087838 bus:FRS102 2023-11-30 2024-11-29 03087838 bus:Audited 2023-11-30 2024-11-29 03087838 bus:FullAccounts 2023-11-30 2024-11-29 03087838 bus:RegisteredOffice 2023-11-30 2024-11-29 03087838 bus:Director2 2023-11-30 2024-11-29 03087838 bus:Director4 2023-11-30 2024-11-29 03087838 bus:Director6 2023-11-30 2024-11-29 03087838 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-11-30 2024-11-29 03087838 bus:PreferenceShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-11-30 2024-11-29 03087838 bus:PreferenceShareClass1 bus:Non-cumulativeRedeemableShares 2023-11-30 2024-11-29 03087838 bus:Consolidated 2023-11-30 2024-11-29 03087838 bus:PrivateLimitedCompanyLtd 2023-11-30 2024-11-29 03087838 bus:Agent1 2023-11-30 2024-11-29 03087838 1 2023-11-30 2024-11-29 03087838 core:FinancialGuarantees 2023-11-30 2024-11-29 03087838 core:FurnitureFittingsToolsEquipment 2023-11-30 2024-11-29 03087838 core:LandBuildings 2023-11-30 2024-11-29 03087838 core:MotorVehicles 2023-11-30 2024-11-29 03087838 core:OtherPropertyPlantEquipment 2023-11-30 2024-11-29 03087838 core:DeferredTaxation 2023-11-30 2024-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-11-30 2024-11-29 03087838 core:OtherRelatedParties 2023-11-30 2024-11-29 03087838 core:ParentEntities 2023-11-30 2024-11-29 03087838 core:UKTax 2023-11-30 2024-11-29 03087838 1 2023-11-30 2024-11-29 03087838 countries:EnglandWales 2023-11-30 2024-11-29 03087838 2023-11-29 03087838 core:FurnitureFittingsToolsEquipment 2023-11-29 03087838 core:LandBuildings 2023-11-29 03087838 core:MotorVehicles 2023-11-29 03087838 core:OtherPropertyPlantEquipment 2023-11-29 03087838 core:DeferredTaxation 2023-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-11-29 03087838 core:OtherRelatedParties 2023-11-29 03087838 core:ParentEntities 2023-11-29 03087838 2022-11-30 2023-11-29 03087838 2023-11-29 03087838 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-11-29 03087838 bus:PreferenceShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-11-29 03087838 core:CurrentFinancialInstruments 2023-11-29 03087838 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-29 03087838 core:CurrentFinancialInstruments core:WithinOneYear 2 2023-11-29 03087838 core:FurnitureFittingsToolsEquipment 2023-11-29 03087838 core:LandBuildings 2023-11-29 03087838 core:MotorVehicles 2023-11-29 03087838 core:OtherPropertyPlantEquipment 2023-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-11-29 03087838 core:OtherRelatedParties 2023-11-29 03087838 core:ParentEntities 2023-11-29 03087838 1 2022-11-30 2023-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-11-30 2023-11-29 03087838 core:OtherRelatedParties 2022-11-30 2023-11-29 03087838 core:ParentEntities 2022-11-30 2023-11-29 03087838 core:UKTax 2022-11-30 2023-11-29 03087838 2022-11-29 03087838 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-11-29 03087838 core:OtherRelatedParties 2022-11-29 03087838 core:ParentEntities 2022-11-29 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03087838

Your Health Limited

Annual Report and Financial Statements

for the Year Ended 29 November 2024

 

Your Health Limited

Contents

Company Information

1

Directors' Report

2 to 3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Profit and Loss Account and Statement of Retained Earnings

8

Balance Sheet

9

Notes to the Financial Statements

10 to 21

 

Your Health Limited

Company Information

Directors

V Weller

Mr D Shaw

Mrs B J Davison-Shaw

Registered office

Holford House
Hearthcote Road
Swadlincote
Derbyshire
DE11 9BX

Auditors

Buckler Spencer Limited Old Police Station
Church Street
Swadlincote
Derbyshire
DE11 8LN

 

Your Health Limited

Directors' Report for the Year Ended 29 November 2024

The directors present their report and the financial statements for the year ended 29 November 2024.

Directors of the company

The directors who held office during the year were as follows:

V Weller

Mr D Shaw

Mrs B J Davison-Shaw

Employment of disabled persons

The company's policy is to promote equaility of opportunity in recruitment, employment continuity, training and career development. The company takes full account of the needs of people with disabilities and follows set policies and procedures to support reasonable adjustments in the workplace.

 

Your Health Limited

Directors' Report for the Year Ended 29 November 2024

Employee involvement

The comapny recognises the importance of its employess and is commiteed to effective two-way communication and consultation. The company recognises the rights of every employee to join a trade union and participate in its activities.

The company recognises its duties to make proper provision for the health, safety and welfare at work of its employees. There are regular meetings of employee representatives and managers to consider all aspects of health and saefty.

Social and community issues

We endeavour to put the rights of our clients at the forefront of our philosophy of care. We strive to maintain those rights in all aspects of the services we provide.

Our standards are based around six recognised principles outlined by the Care Quality Commission, which are Privacy, Dignity, Independence, Choice, Rights and Fulfilment.

We aim to ensure that our service users enjoy a freedom of lifestyle, while receiving excellent levels of care.

We take great pride in introducing our care homes and domiciliary care service to you. At every turn we ensure the maximum comfort, wellbeing and happiness of our service users, while special attention is paid to the importance of respect for each resident and the continuance of their personal dignity.

We recognise the intrinsic value of people, and respect all of our residents’ uniqueness and varying needs. We provide plenty of enjoyment and, even more essentially, lots of tender, loving care.

Our carers and support staff members are truly dedicated, highly motivated and committed to maintaining excellent standards of care. All of our passionate staff members are encouraged to embrace residents’ requirements to ensure maximum comfort, wellbeing and happiness.

Going concern

Based on current performance and business plans for the future, the directors the company will continue as a going concern for the forseeable future. This is due to the improved occupancy rates over the year.

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Approved and authorised by the Board on 27 August 2025 and signed on its behalf by:
 

.........................................
Mr D Shaw
Director

 

Your Health Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Your Health Limited

Independent Auditor's Report to the Members of Your Health Limited

Opinion

We have audited the financial statements of Your Health Limited (the 'company') for the year ended 29 November 2024, which comprise the Profit and Loss Account and Statement of Retained Earnings, Balance Sheet, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 29 November 2024 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

 

Your Health Limited

Independent Auditor's Report to the Members of Your Health Limited

the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities [set out on page 4], the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Your Health Limited

Independent Auditor's Report to the Members of Your Health Limited

We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates and, considered the risk of acts by management and the directors of the company which were contrary to applicable laws and regulations, including fraud. These included but were not limited to compliance with the Companies Act 2006 and the Financial Reporting Standard 102. We made enquiries of the directors of the company to obtain further understanding of risks of non-compliance.

We focused on laws and regulations that could give rise to a material misstatement in the financial statements. Our tests included, but were not limited to:

• agreement of the financial statement disclosures to underlying supporting documentation;
• enquiries of management regarding known or suspected instances of non-compliance with laws and regulations;
• review of minutes of the director and management board meetings throughout the year; and
• obtaining an understanding of the control environment in place to prevent and detect irregularities.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are
inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Mr Richard Spencer BA FCA (Senior Statutory Auditor)
For and on behalf of Buckler Spencer Limited, Statutory Auditor
 Old Police Station
Church Street
Swadlincote
Derbyshire
DE11 8LN

27 August 2025

 

Your Health Limited

Profit and Loss Account and Statement of Retained Earnings for the Year Ended 29 November 2024

Note

2024
£

2023
£

Turnover

3

14,061,676

12,686,369

Cost of sales

 

(8,505,438)

(7,422,759)

Gross profit

 

5,556,238

5,263,610

Administrative expenses

 

(4,292,906)

(4,385,373)

Other operating income

4

119,056

57,464

Operating profit

6

1,382,388

935,701

Gain on financial assets at fair value through profit and loss

 

-

78,905

Other interest receivable and similar income

7

144,595

32,699

Interest payable and similar charges

8

(50,000)

(50,000)

 

94,595

61,604

Profit before tax

 

1,476,983

997,305

Taxation

11

(386,376)

(289,632)

Profit for the financial year

 

1,090,607

707,673

Retained earnings brought forward

 

3,705,579

2,997,906

Retained earnings carried forward

 

4,796,186

3,705,579

 

Your Health Limited

(Registration number: 03087838)
Balance Sheet as at 29 November 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

12

3,993,948

4,035,058

Investment property

13

375,000

375,000

 

4,368,948

4,410,058

Current assets

 

Stocks

14

866

784

Debtors

15

2,718,083

1,135,670

Cash at bank and in hand

 

5,537,715

4,398,511

 

8,256,664

5,534,965

Creditors: Amounts falling due within one year

17

(6,477,924)

(4,860,942)

Net current assets

 

1,778,740

674,023

Total assets less current liabilities

 

6,147,688

5,084,081

Provisions for liabilities

18

(101,500)

(128,500)

Net assets

 

6,046,188

4,955,581

Capital and reserves

 

Called up share capital

1,250,002

1,250,002

Retained earnings

4,796,186

3,705,579

Shareholders' funds

 

6,046,188

4,955,581

Approved and authorised by the Board on 27 August 2025 and signed on its behalf by:
 

.........................................
Mr D Shaw
Director

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Holford House
Hearthcote Road
Swadlincote
Derbyshire
DE11 9BX

These financial statements were authorised for issue by the Board on 27 August 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

The company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year are addressed below:

Asset depreciation

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentation currency is British pounds rounded to the nearest £1.

Summary of disclosure exemptions

The comapny has taken advantage of provisions in FRS 102 relating to 100% owned group companies which include:

Requirements under section 7 to prepare a cash flow statement;
Requirement under section 414 to prepare a strategic report;
Reqiurement to disclose key management personal compensation under section 33.7..

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities within the care home industry. Turnover also includes services performed in the management of the accounting function for associated companies and related parties. Turnover also includes monies received as rental payment for the investment property owned by the company. Turnover is shown net of rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Deferred tax assets are only recognised where it is more likely than not that they will be recovered.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

20% on cost after year of acquisition

Other property, plant and equipment

10% on cost after year of acquisition

Motor Vehicles

25% on cost after year of acquisition

Freehold Property

2% on cost after year of acquisition

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined periodically by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Preference shares have been allocated 50% equity and 50% liabilities in accordance with current guidelines.

Defined contribution pension obligation

The company has a work place pension scheme which operates under a defined contribution basis. During the year the cost for this was £122,370 (2023 £105,441). At the year end there was £38,070 (2023 £58,842) of outstanding contributions within the balance sheet.

3

Turnover

The analysis of the company's turnover for the year from continuing operations is as follows:

2024
£

2023
£

Sale of goods

14,051,776

12,673,919

Rental income from investment property

9,900

11,700

Grants received

-

750

14,061,676

12,686,369

4

Other operating income

The analysis of the company's other operating income for the year is as follows:

2024
£

2023
£

Related company cost recoveries

119,056

57,464

5

Other gains and losses

The analysis of the company's other gains and losses for the year is as follows:

2024
 £

2023
 £

Gain/loss on disposal of property, plant and equipment

875

-

6

Operating profit

Arrived at after charging/(crediting)

2024
 £

2023
 £

Depreciation expense

319,442

326,472

Operating lease expense - other

7,493

6,831

Profit on disposal of property, plant and equipment

(875)

-

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

7

Other interest receivable and similar income

2024
£

2023
£

Interest income on bank deposits

144,595

32,699

8

Interest payable and similar expenses

2024
£

2023
£

Interest expense on other finance liabilities

50,000

50,000

9

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2024
£

2023
£

Wages and salaries

7,124,399

6,210,299

Social security costs

550,275

431,215

Other post-employment benefit costs

122,370

105,441

Other employee expense

1,732,912

2,028,298

9,529,956

8,775,253

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2024
No.

2023
No.

Administration and support

24

28

Other departments

303

287

327

315

10

Auditors' remuneration

2024
 £

2023
 £

Audit of the financial statements

13,854

12,300


 

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

11

Taxation

Tax charged/(credited) in the profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax

413,376

250,132

Deferred taxation

Arising from changes in tax rates and laws

(27,000)

39,500

Tax expense in the income statement

386,376

289,632

The tax on profit before tax for the year is the same as the standard rate of corporation tax in the UK (2023 - the same as the standard rate of corporation tax in the UK) of 25% (2023 - 25%).

The differences are reconciled below:

2024
£

2023
£

Profit before tax

1,476,983

997,305

Corporation tax at standard rate

369,246

249,326

Tax increase from effect of capital allowances and depreciation

17,130

40,306

Total tax charge

386,376

289,632

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

12

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Total
£

Cost or valuation

At 30 November 2023

4,132,558

1,628,505

449,324

494,631

6,705,018

Additions

182,661

35,737

28,774

41,082

288,254

At 29 November 2024

4,315,219

1,664,242

478,098

535,713

6,993,272

Depreciation

At 30 November 2023

913,315

1,209,097

326,078

221,470

2,669,960

Charge for the year

84,499

178,066

19,302

47,497

329,364

At 29 November 2024

997,814

1,387,163

345,380

268,967

2,999,324

Carrying amount

At 29 November 2024

3,317,405

277,079

132,718

266,746

3,993,948

At 29 November 2023

3,219,243

419,408

123,246

273,161

4,035,058

Included within the net book value of land and buildings above is £3,317,405 (2023 - £3,219,243) in respect of freehold land and buildings.
 

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

13

Investment properties

2024
£

At 30 November

375,000

At 29 November

375,000

There has been no valuation of investment property by an independent valuer.

14

Stocks

2024
£

2023
£

Other inventories

866

784

15

Debtors

Current

Note

2024
£

2023
£

Trade debtors

 

870,681

871,126

Amounts owed by related parties

22

1,614,915

83,234

Other debtors

 

228,612

177,435

Income tax asset

11

3,875

3,875

   

2,718,083

1,135,670

16

Cash and cash equivalents

2024
£

2023
£

Cash on hand

11,836

5,003

Cash at bank

5,525,879

4,393,508

5,537,715

4,398,511

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

17

Creditors

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

20

1,250,000

1,250,000

Trade creditors

 

766,783

798,173

Amounts due to related parties

22

1,877,149

1,773,799

Social security and other taxes

 

648,500

399,165

Other payables

 

1,606,649

403,777

Accruals

 

328,843

236,028

 

6,477,924

4,860,942

18

Deferred tax and other provisions

Deferred tax
£

Total
£

At 30 November 2023

128,500

128,500

Additional provisions

(27,000)

(27,000)

At 29 November 2024

101,500

101,500

Deferred tax provision is due to accelerated capital allowances.

19

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

2

2

2

2

Preference Shares of £1 each

1,250,000

1,250,000

1,250,000

1,250,000

1,250,002

1,250,002

1,250,002

1,250,002

Redeemable preference shares

The Preference Shares are redeemable. They are redeemable at £1 per share and carry no voting rights. Winding up value for redeemable preference shares is £1-.

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

20

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Redeemable preference shares

1,250,000

1,250,000

Other borrowings

Preference shares is denominated in sterling with a nominal interest rate of 4%, and the final instalment is due on 30 November 2025. The carrying amount at year end is £1,250,000 (2023 - £1,250,000).

Repayable within one year or on demand.

21

Contingent liabilities

The company is party to an unlimited cross-guarantee in respect of group borrowings. There are currently no borrowings in the group to report.

22

Related party transactions

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

Summary of transactions with other related parties

Company performs basic management and administration transactions for companies with the same owners. These transactions are in the normal course of business and at arms length. The companies involved are Clearfact Ltd, Leading Contracts Ltd, Cedar Court Properties Ltd, Your Health Training Ltd, System Associates Ltd and Belle Toute Lighthouse Ltd.

Loans to related parties

2024

Parent
£

Other related parties
£

Total
£

At start of period

95,058

83,633

178,691

Advanced

1,483,510

18,624

1,502,134

Repaid

(25,782)

-

(25,782)

At end of period

1,552,786

102,257

1,655,043

2023

Parent
£

Other related parties
£

Total
£

At start of period

(122,152)

33,600

(88,552)

Advanced

253,799

50,033

303,832

Repaid

(36,589)

-

(36,589)

At end of period

95,058

83,633

178,691

 

Your Health Limited

Notes to the Financial Statements for the Year Ended 29 November 2024

Loans from related parties

2024

Key management
£

Other related parties
£

Total
£

At start of period

(196,073)

(1,773,799)

(1,969,872)

Advanced

333,596

81,744

415,340

Repaid

(1,523,510)

(185,094)

(1,708,604)

At end of period

(1,385,987)

(1,877,149)

(3,263,136)

2023

Key management
£

Other related parties
£

Total
£

At start of period

(207,073)

(1,416,650)

(1,623,723)

Advanced

11,000

(357,149)

(346,149)

At end of period

(196,073)

(1,773,799)

(1,969,872)

23

Parent and ultimate parent undertaking

The company's immediate parent is Farrowdale Properties Ltd, incorporated in British Virgin Islands.

 The most senior parent entity producing publicly available financial statements is Farrowdale Properties Ltd. These financial statements are available upon request from companies house

 The ultimate controlling party is D Shaw and B Davison-Shaw.